Catalyst Wire Dossier Catalyst Wire Dossier

Avadomide

avadomide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avadomide, covering 2022-09-28 to 2022-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma [Phase 2]

See pricing